DNAH2 and clear cell renal carcinoma: DNAH2 mutation was reported in Parkinson’s disease (Gaare et al., 2018), autism (Butler et al., 2015), adult-onset hearing loss (Lewis et al., 2018), and clear cell renal cell carcinomas (Arai et al., 2015).